miR-122 modulates the inactive form of SREBP-2, and a significant decrease in miR-122 has been found in patients with NASH, potentially explaining the increase in SREBP-2 [49]. The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatohepatitis.